PACIRA PHARMACEUTICALS
Pacira Pharmaceuticals Inc. operates as a pharmaceutical company which engages in the development and manufacturing of injectable pharmaceutical products. Pacira Pharmaceuticals Inc. was formerly known as DepoTech Corp. was formerly as SkyePharma Inc. and changed its name to Pacira Pharmaceuticals Inc. in June, 2007. The company was founded in 1989 and is based in San Diego, California. Pacira Pharmaceuticals Inc. operates as a subsidiary of Pacira, Inc.
PACIRA PHARMACEUTICALS
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
1989-01-01
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.pacira.com
Total Employee:
501+
Status:
Active
Contact:
973-254-3560
Total Funding:
112.5 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager Content Delivery Network Google Universal Analytics Apache Global Site Tag
Similar Organizations
Salix Pharmaceuticals
Salix Pharmaceuticals is a specialty pharmaceutical company focused on the prevention and treatment of gastrointestinal disorders.
Current Advisors List
Board_member
Board_member
2011-01-01
Board_member
Current Employees Featured
Paul R. Ellwood Vice President, Human Resources @ Pacira Pharmaceuticals
Vice President, Human Resources
Roy Winston Chief Medical Officer @ Pacira Pharmaceuticals
Chief Medical Officer
2021-07-01
John Bartolick Vice President IT @ Pacira Pharmaceuticals
Vice President IT
2014-01-01
Dennis McLoughlin Chief Customer Officer @ Pacira Pharmaceuticals
Chief Customer Officer
2017-01-01
Paul J. Hastings Lead Independent Director @ Pacira Pharmaceuticals
Lead Independent Director
2011-06-01
Donald C. Manning Chief Medical Officer @ Pacira Pharmaceuticals
Chief Medical Officer
2020-05-01
David Stack Chief Executive Officer & Chairman @ Pacira Pharmaceuticals
Chief Executive Officer & Chairman
Charles A. Reinhart III Chief Financial Officer @ Pacira Pharmaceuticals
Chief Financial Officer
2016-04-01
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2021-10-11 | Flexion Therapeutics | Flexion Therapeutics acquired by Pacira Pharmaceuticals | 427.5 M USD |
| 2019-03-05 | MyoScience | MyoScience acquired by Pacira Pharmaceuticals | 220 M USD |
Investors List
Oxford Finance LLC
Oxford Finance LLC investment in Post-IPO Debt - Pacira Pharmaceuticals
Sanderling Ventures
Sanderling Ventures investment in Series A - Pacira Pharmaceuticals
OrbiMed
OrbiMed investment in Series A - Pacira Pharmaceuticals
HBM Healthcare Investments AG
HBM Healthcare Investments AG investment in Series A - Pacira Pharmaceuticals
MPM Capital
MPM Capital investment in Series A - Pacira Pharmaceuticals
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-04-11 | CarthroniX | Pacira Pharmaceuticals investment in Convertible Note - CarthroniX | 2.25 M USD |
| 2022-03-28 | Spine BioPharma | Pacira Pharmaceuticals investment in Series B - Spine BioPharma | 13 M USD |
| 2022-01-07 | Genascence | Pacira Pharmaceuticals investment in Series A - Genascence | 10.5 M USD |
| 2021-12-02 | CODA Biotherapeutics | Pacira Pharmaceuticals investment in Venture Round - CODA Biotherapeutics | 28 M USD |
| 2021-04-20 | Spine BioPharma | Pacira Pharmaceuticals investment in Convertible Note - Spine BioPharma | 3 M USD |
| 2021-02-15 | GeneQuine Biotherapeutics GmbH | Pacira Pharmaceuticals investment in Series A - GeneQuine Biotherapeutics GmbH | 5.4 M EUR |
| 2021-02-15 | GeneQuine Biotherapeutics GmbH | Pacira Pharmaceuticals investment in Debt Financing - GeneQuine Biotherapeutics GmbH | 2.75 M EUR |
| 2020-08-28 | AVALON.AI | Pacira Pharmaceuticals investment in Seed Round - AVALON.AI | 1.5 M USD |
| 2017-10-30 | TELA Bio | Pacira Pharmaceuticals investment in Venture Round - TELA Bio | 25 M USD |
Newest Events participated
Participated in American Association of Nurse Anesthetists (AANA) 2017 Annual Congress
on 2017-09-08 as exhibitor
Official Site Inspections
http://www.pacira.com Semrush global rank: 2.77 M Semrush visits lastest month: 5.85 K
- Host name: 141.193.213.21
- IP address: 141.193.213.21
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Pacira Pharmaceuticals"
A leader in innovative pain management – About Pacira
An organization’s power comes from its purpose. For over a decade, ours has been addressing patients’ unmet pain management needs with a best-in-class portfolio of products. Our non-opioid solutions have created new opportunities …See details»
Our leadership - Pacira
Meet our leadership team: seasoned veterans in pain management dedicated to delivering innovative, patient-centered solutions.See details»
About us - Pacira
Pacira core values We are a team of dedicated and highly talented professionals focused on driving improved patient outcomes with opioid-reducing strategies. We are an organization built on high ethical standards, an unwavering …See details»
Pacira Announces New Five-Year Objectives to Accelerate
Jan 10, 2025 Pacira Announces New Five-Year Objectives to Accelerate Transition into an Innovative Biopharmaceutical Organization Company also reports preliminary unaudited 2024 …See details»
Pacira Company Profile | Management and Employees List
Pacira Profile and History Pacira is the leading provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving patient outcomes. We …See details»
Pacira Announces New Five-Year Objectives to Accelerate …
Jan 10, 2025 Company also reports preliminary unaudited 2024 revenue of $701.0 millionPARSIPPANY, N.J., Jan. 10, 2025 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. …See details»
Pacira Pharmaceuticals - Crunchbase Company Profile & Funding
Pacira Pharmaceuticals Inc. operates as a pharmaceutical company which engages in the development and manufacturing of injectable pharmaceutical products. Pacira …See details»
Pacira BioSciences Announces First Patient Dosed in Phase 2 Study ...
1 hour ago Pacira BioSciences Announces First Patient Dosed in Phase 2 Study Evaluating Safety and Efficacy of PCRX-201 for the Treatment of Osteoarthritis of the Knee ... as well as …See details»
Culture – Life at Pacira
Discover Pacira’s dynamic workplace culture, where innovation, collaboration and a passion for improving patient care drive everything we do. ... This activity supports the organization’s …See details»
Pacira Announces New Five-Year Objectives to ... - Markets Insider
Jan 10, 2025 Pacira Announces New Five-Year Objectives to Accelerate Transition into an Innovative Biopharmaceutical Organization PRESS RELEASE GlobeNewswire Jan. 10, 2025, …See details»
Investor FAQ | Pacira BioSciences, Inc.
Feb 3, 2011 In April 2019, we changed our name to Pacira BioSciences, Inc. Press space to expand and collapse this section. When was Pacira’s initial public offering what was the …See details»
Pacira Biosciences Expands Vision as Innovative Biopharmaceutical ...
Feb 27, 2025 Breaking News Pacira Biosciences Advances to Become Innovative Biopharmaceutical OrganizationIn a significant development for the biopharmaceutical …See details»
Pacira Announces New Five-Year Objectives to Accelerate
Jan 10, 2025 Pacira Announces New Five-Year Objectives to Accelerate Transition into an Innovative Biopharmaceutical Organization Provided by GlobeNewswire Jan 10, 2025 1:00pmSee details»
Pacira Pharmaceuticals, Inc.
©2025 Pacira Pharmaceuticals, Inc., a wholly owned subsidiary of Pacira BioSciences, Inc. PP-MP-US-0289 Cookies are used on this site to assist in continually improving the candidate …See details»
Medical missions and charitable contributions – Pacira
Discover how Pacira supports global medical missions by providing non-opioid pain management solutions to underserved communities in need. ... Letter of request on the requesting …See details»
Pacira
Pacira is a global pharmaceutical company and a leading provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving patient …See details»
Corporate governance - highlights | Pacira BioSciences, Inc.
Pacira BioSciences views ethical business practices and accountability as fundamental to its corporate philosophy. It is Pacira's responsibility and commitment to its shareholders, patients …See details»
Our impact - Pacira
Advocating for non-opioid access in the U.S. We believe everyone deserves access to safe pain management options. That’s why we proudly provided the seed funding to help establish …See details»
Pacira BioSciences Announces First Patient Dosed in Phase 2 Study ...
1 hour ago Pacira BioSciences Announces First Patient Dosed in Phase 2 Study Evaluating Safety and Efficacy of PCRX-201 for the Treatment of Osteoarthritis of the Knee Pacira …See details»
Pacira BioSciences Announces First Patient Dosed in Phase 2 Study ...
1 hour ago BRISBANE, Calif., April 03, 2025 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to deliver innovative, non-opioid pain …See details»